160 related articles for article (PubMed ID: 21430993)
1. Gene expressions of nitric oxide synthase and matrix metalloproteinase-2 in monocrotaline-induced pulmonary hypertension in rats after bosentan treatment.
Koo HS; Kim KC; Hong YM
Korean Circ J; 2011 Feb; 41(2):83-90. PubMed ID: 21430993
[TBL] [Abstract][Full Text] [Related]
2. Gene expression of endothelin-1 and endothelin receptor a on monocrotaline-induced pulmonary hypertension in rats after bosentan treatment.
Lim KA; Kim KC; Cho MS; Lee BE; Kim HS; Hong YM
Korean Circ J; 2010 Sep; 40(9):459-64. PubMed ID: 20967148
[TBL] [Abstract][Full Text] [Related]
3. Changes of pulmonary pathology and gene expressions after simvastatin treatment in the monocrotaline-induced pulmonary hypertension rat model.
Lee YH; Kim KC; Cho MS; Hong YM
Korean Circ J; 2011 Sep; 41(9):518-27. PubMed ID: 22022327
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats.
Nakazawa H; Hori M; Ozaki H; Karaki H
Br J Pharmacol; 1999 Nov; 128(5):1098-104. PubMed ID: 10556948
[TBL] [Abstract][Full Text] [Related]
5. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats.
Kanno S; Wu YJ; Lee PC; Billiar TR; Ho C
Circulation; 2001 Aug; 104(8):945-50. PubMed ID: 11514384
[TBL] [Abstract][Full Text] [Related]
7. Changes of gene expression after bone marrow cell transfusion in rats with monocrotaline-induced pulmonary hypertension.
Kim KC; Lee HR; Kim SJ; Cho MS; Hong YM
J Korean Med Sci; 2012 Jun; 27(6):605-13. PubMed ID: 22690090
[TBL] [Abstract][Full Text] [Related]
8. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats.
Yip HK; Chang LT; Sun CK; Sheu JJ; Chiang CH; Youssef AA; Lee FY; Wu CJ; Fu M
Crit Care Med; 2008 Mar; 36(3):873-80. PubMed ID: 18431275
[TBL] [Abstract][Full Text] [Related]
9. Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathway.
Li H; Lu W; Cai WW; Wang PJ; Zhang N; Yu CP; Wang DL; Liu BC; Sun W
Pulm Pharmacol Ther; 2014 Jun; 28(1):17-24. PubMed ID: 24269521
[TBL] [Abstract][Full Text] [Related]
10. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension.
Kanki-Horimoto S; Horimoto H; Mieno S; Kishida K; Watanabe F; Furuya E; Katsumata T
Circulation; 2006 Jul; 114(1 Suppl):I181-5. PubMed ID: 16820570
[TBL] [Abstract][Full Text] [Related]
11. An inhibitory effect of tumor necrosis factor-alpha antagonist to gene expression in monocrotaline-induced pulmonary hypertensive rats model.
Kwon JH; Kim KC; Cho MS; Kim HS; Sohn S; Hong YM
Korean J Pediatr; 2013 Mar; 56(3):116-24. PubMed ID: 23559973
[TBL] [Abstract][Full Text] [Related]
12. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats.
Lee H; Lee JC; Kwon JH; Kim KC; Cho MS; Yang YS; Oh W; Choi SJ; Seo ES; Lee SJ; Wang TJ; Hong YM
J Korean Med Sci; 2015 May; 30(5):576-85. PubMed ID: 25931788
[TBL] [Abstract][Full Text] [Related]
14. Effect of Benidipine Alone and in Combination With Bosentan and Sildenafil in Amelioration of Pulmonary Arterial Hypertension in Experimental Model in Rats.
Kumari K; Vishwakarma VK; Kumar K; Mridha AR; Arava SK; Dhingra S; Singh N; Yadav HN
J Cardiovasc Pharmacol; 2024 Apr; 83(4):330-339. PubMed ID: 38241693
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis and inflammation associated gene expressions in monocrotaline-induced pulmonary hypertensive rats after bosentan treatment.
Hong YM; Kwon JH; Choi S; Kim KC
Korean Circ J; 2014 Mar; 44(2):97-104. PubMed ID: 24653739
[TBL] [Abstract][Full Text] [Related]
16. Benefit of combined therapy with nicorandil and colchicine in preventing monocrotaline-induced rat pulmonary arterial hypertension.
Lee FY; Lu HI; Zhen YY; Leu S; Chen YL; Tsai TH; Chung SY; Chua S; Sheu JJ; Hsu SY; Chang HW; Sun CK; Yip HK
Eur J Pharm Sci; 2013 Nov; 50(3-4):372-84. PubMed ID: 23954457
[TBL] [Abstract][Full Text] [Related]
17. Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway.
Gao H; Cheng Y; Zong L; Huang L; Qiao C; Li W; Gong B; Hu J; Liu H; Wang X; Zhao C
Clin Exp Hypertens; 2017; 39(1):34-41. PubMed ID: 28055284
[TBL] [Abstract][Full Text] [Related]
18. [Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].
Li XL; Guan RJ; Xu QH; Wu ZY
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):247-53. PubMed ID: 21609531
[TBL] [Abstract][Full Text] [Related]
19. [Effects of apple polyphenols on monocrotaline-induced pulmonary vascular remodeling in rats and its mechanism].
Zhang SH; Shao SM; Chen FZ; Zhu J; Chen LW; Wang H; Xiang XH; Yuan LB
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2019 May; 35(3):209-214. PubMed ID: 31257800
[TBL] [Abstract][Full Text] [Related]
20. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
Hill NS; Warburton RR; Pietras L; Klinger JR
J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]